The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictive markers for clinical outcome after neoadjuvant radiochemotherapy in breast cancer patients.
Christiane Matuschek
No relevant relationships to disclose
Edwin Boelke
No relevant relationships to disclose
Hans Bojar
No relevant relationships to disclose
Werner Audretsch
No relevant relationships to disclose
Hans Bernd Prisack
No relevant relationships to disclose
Wilfried Budach
No relevant relationships to disclose
Carolin Nestle-Kraemling
No relevant relationships to disclose